Tag: AI Drug Discovery
AbbVie signs a multi-year AI deal as Iambic files for Nasdaq
The San Diego drug designer lands a large pharma partner days before asking public investors to fund its pipeline.
LeCun and Moderna founder Langer join a cell modeling startup
Cellular Intelligence wants a foundation model that predicts how cells respond to sequences of signals.
An AI biotech of 37,000 agents flags a lung cancer target
A Stanford team built a virtual drug company staffed by 37,000 AI agents, and it has flagged a lung cancer…
Anthropic opens a wet lab to test Claude at the bench
Anthropic has built a San Francisco Bay Area wet lab so Claude can direct real biology experiments, pushing its drug…
Lilly’s TuneLab network adds two wet-lab data partners
Ginkgo Datapoints and Twist Bioscience will feed experimental data into Eli Lilly's shared AI drug discovery models.
Mithrl raises $20M for a biomedical world model aimed at R&D
The company says its platform can cut the time from a research idea to an investigational new drug filing by…
Anew Labs leaves ByteDance with $290M to design drugs with AI
The Shanghai spinout's first outside round values the young company near $1.5B and keeps ByteDance as its largest shareholder.
Proteomics model picks breast cancer drugs from biopsies
A virtual-cell model trained on 38 million protein measurements matched real treatment outcomes in women with triple-negative breast cancer.